Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase | Taiwan News taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.
Medtronic reported Q4 2024 sales of $8.59 billion, with 0.5% reported and 5.4% organic revenue growth. Dividend increased to $0.70 per share. FY 2025 EPS guidance is $5.40-$5.50.
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business.